COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts (Q44185593)

30 November 2017

title

COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts (English)

1 reference

30 November 2017

0 references

5

Roberto Bolli

1 reference

30 November 2017

Ken Shinmura

1

1 reference

30 November 2017

Maiko Nagai

series ordinal

2

1 reference

30 November 2017

Kayoko Tamaki

series ordinal

3

1 reference

30 November 2017

Masato Tani

series ordinal

4

1 reference

30 November 2017

publication date

8 August 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

30 November 2017

published in

1 reference

30 November 2017

volume

283

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

H2534-43

1 reference

Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

The late phase of preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Ischemia and reperfusion induced formation of eicosanoids in isolated rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Beneficial effects of iloprost in the stunned canine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Essential activation of PKC-delta in opioid-initiated cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Ischemic Preconditioning Induces Selective Translocation of Protein Kinase C Isoforms and in the Heart of Conscious Rabbits Without Subcellular Redistribution of Total Protein Kinase C Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Ischaemic preconditioning: present position and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

Human gene encoding prostacyclin synthase (PTGIS): genomic organization, chromosomal localization, and promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00209.2002

10.1152/AJPHEART.00209.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference